Related Experiment Videos
[Cardiomyopathies (VII). Natural history of hypertrophic cardiomyopathy]
C Sáenz de la Calzada1, R Tello de Meneses, J Delgado Jiménez
1Servico de Cardiología, Hospital 12 de Octubre, Madrid.
Insights
Hypertrophic cardiomyopathy analysis reveals that while diastolic dysfunction and LV obstruction cause symptoms, they don't increase sudden death risk. Myocardial ischemia may signal risk in specific young patients.
Area of Science:
- Cardiology
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition with varied clinical presentations.
- Understanding its natural history and risk factors for adverse outcomes is crucial for patient management.
Purpose of the Study:
- To analyze the natural history of hypertrophic cardiomyopathy based on its morphologic and functional abnormalities.
- To evaluate the association between specific HCM features and the risk of sudden cardiac death.
- To review recent advancements in understanding the genetic basis of HCM.
Main Methods:
- Review of conceptual developments and historical context of HCM.
- Analysis of morphologic and functional abnormalities in relation to disease progression.
- Examination of prognostic implications of myocardial ischemia and genetic mutations.
Main Results:
- Hypertrophic morphology alone is not associated with sudden death.
- Diastolic dysfunction and left ventricular (LV) obstruction are not risk factors for sudden death, though they cause dyspnea and heart failure.
- Myocardial ischemia is common in HCM; a positive Thallium effort test in young patients with a family history of sudden death may indicate risk.
Conclusions:
- Specific functional abnormalities in HCM do not uniformly predict sudden cardiac death.
- Myocardial ischemia warrants further investigation for prognostic value, particularly in at-risk populations.
- Emerging genetic insights are reshaping the understanding and future management of hypertrophic cardiomyopathy.
Abstract:
After a short historic review of conceptual developments in hypertrophic cardiomyopathy, the natural history of the disease is analyzed according to each of its morphologic and functional abnormalities. The lack of association between hypertrophic morphology and sudden death is considered. Diastolic dysfunction and LV obstruction, although a frequent cause of dyspnea and heart failure, is not a risk factor for sudden death. Something similar occurs with the infrequent appearance in this disease of contractile failure. Myocardial ischemia is frequent in hypertrophic cardiomyopathy and general prognostic information about it is still lacking. Nevertheless, in young patients with family history of sudden death, a positive Thallium effort test may be a marker of sudden death (without an arrhythmogenic substrate), and may respond to verapamil. Finally, the new knowledge about genetic mutations in hypertrophic cardiomyopathy are analized. We conclude with some futuristic comments about hypertrophic cardiomyopathy.